Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

GYRE
Gyre Therapeutics, Inc.US flagNASDAQ Capital Market
6.06
USD
+0.18
- -
553.83MMarket Cap

Gyre Therapeutics, Inc. (GYRE) Stock Split History

Learn about Gyre Therapeutics, Inc.'s most recent 1-for-15 basis stock split on October 31, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Gyre Therapeutics, Inc.'s most recent stock split

Split Date: 2023-10-31
Split Ratio: 1:15
Price Before Split: $0.45
Price After Split: $0.03

Developer API

Get GYRE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/GYRE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Gyre Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-10-311:15Yes$0.45$0.03
2017-02-131:15Yes$0.63$0.04
2015-08-211:7Yes$1.27$0.18

About Gyre Therapeutics, Inc.

Company overview and industry information

Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Gyre Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.